Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

aTyr Pharma, Inc.

TRADE

NASDAQ: LIFEHealthcare / Biotechnology / USA
0.75+0.05+7.14%Vol 702 6481Y Perf -86.11%
Oct 17th, 2018 13:31
BID0.74 ASK0.75
Open0.70 Previous Close0.70
Pre-Market0.74 After-Trading0.70
 0.04 5.71%  - -%
Target Price
1.18 
Analyst Rating
Moderate Buy 2.50
Potencial %
57.33 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/33 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/89 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/97 
Income Ranking
 —    -
Market Cap (mil)22 
Earnings Rating
Sell
Price Range Ratio 52wk %
2.97 
Earnings Date
13th Nov 2018

Today's Price Range

0.700.78

 

52wk Range

0.605.65

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-6.67%
3 Months
-21.35%
6 Months
-72.55%
1 Year
-86.11%
3 Years
-93.87%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
LIFE0.750.05007.14
AAPL221.93-0.2200-0.10
GOOG1 117.94-3.3400-0.30
MSFT110.89-0.1100-0.10
XOM81.260.06000.07
WFC54.761.03001.92
JNJ139.522.96002.17
FB159.250.47000.30
GE12.290.19001.57
JPM110.401.78001.64
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.80
Current Ratio 6.00
Long Term Debt to Total Capital 0.21
Total Debt to Equity 0.43
Interest Coverage -
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.48
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.70
Cash Flow Per Share -1.35
Price to Tangible Book0.48
Book Value per Share1.52
Enterprise Value (in ths.)-22 966
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-186.52
ROE last 12 Months -101.36
Return on Assets (5Y Avg) -62.55
ROA last 12 Months -66.69
Return on Capital (5Y Avg) -
ROC last 12 Months -73.18
Return on invested Capital Q -14.94
Return on invested Capital Y-61.68
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.34-0.35-2.94
Q01 2018-0.35-0.36-2.86
Q04 2017-0.43-0.399.30
Q03 2017-0.51-0.4315.69
Q02 2017-0.57-0.5110.53
Q01 2017-0.55-0.56-1.82
Q04 2016-0.61-0.5313.11
Q03 2016-0.67-0.5813.43
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.30-3.45Negative
12/2018 QR-0.289.68Positive
12/2018 FY-1.29-0.78Negative
12/2019 FY-1.217.63Positive
Next Report Date13th Nov 2018
Estimated EPS Next Report-0.30
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume702 648
Shares Outstanding (in ths.)29 860
Trades Count717
Dollar Volume472 053
Avg. Volume453 063
Avg. Weekly Volume433 808
Avg. Monthly Volume374 662
Avg. Quarterly Volume502 305

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

59%41%

Bearish Bullish

57%43%

Bearish Bullish

79%21%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (25.00 %)
1 (25.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (75.00 %)
3 (75.00 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
RatingModerate Buy
2.50
Moderate Buy
2.50
Hold
3.00

There are no comments yet.

News

x